In the BioHarmony Drug Report Database

"Preview" Icon

Dacarbazine

Dtic-dome (dacarbazine) is a small molecule pharmaceutical. Dacarbazine was first approved as Dtic-dome on 1982-01-01. It is used to treat fibrosarcoma, hodgkin disease, islet cell carcinoma, medullary carcinoma, and melanoma amongst others in the USA.

 

Trade Name

 

Dtic-dome
 

Common Name

 

dacarbazine
 

ChEMBL ID

 

CHEMBL476
 

Indication

 

fibrosarcoma, hodgkin disease, islet cell carcinoma, medullary carcinoma, melanoma, neuroblastoma, rhabdomyosarcoma
 

Drug Class

 

Image (chem structure or protein)

Dacarbazine structure rendering